“showed a trend”

Patients treated with combination therapy showed a trend toward a longer PFS if an irAE was documented [9.7 months vs. 7.1 months, (HR, 0.50; 95% CI, 0.25–1.02; P = 0.053); Fig. 1 c].

In patients who were given chemotherapy, high LAIR-1 expression showed a trend of shorter patient survival (HR = 1.0, 95% CI 0.8–1.6, p = 0.053: Figure 4 A).

All-cause mortality during follow-up showed a trend towards statistically significant difference across the groups ( p = 0.053), with the highest proportion of deaths occurring in the LL group (51.4%) compared to the HH (29.3%) and VAR (30.5%) groups.

Follow-up showed a trend toward fewer complications (2.5% vs. 8.5%, p = 0.053).

Notably, estriol use during radiotherapy showed a trend toward reducing subjective vaginal dryness (r=–0.297, p =0.053), highlighting its potential role in mitigating vaginal toxicity.

Tumor size, analyzed as a continuous variable, showed a trend toward worse outcomes, approaching significance for OS (HR 1.290; 95% CI, 0.997-1.660; P = .053; Table 4 ) and for RFS (HR 1.297; 95% CI, 0.979-1.717; P = .070; Table 3 ).

Among CC FD metrics, both uncorrected CC FD total area and proportional area showed a trend toward increase during 24 months follow-up with nAMD development (p = 0.053 and p = 0.053, respectively; Table 4 and Figure 4 ).

Notably, Imeglimin + Metformin showed a trend toward HbA1c reduction versus control (p=0.053), while Imeglimin monotherapy did not differ significantly from control.

Medium and small body size were not significantly associated with NT after adjustment, although medium-sized dogs again showed a trend (OR = 1.42, 95% CI: 0.99–2.05, p = 0.053).

3D LGE showed a trend toward higher image quality scores (3D: 4 [3, 4], 2D: 3 [2, 4], P = 0.053) in patients with respiratory motion artifacts on 2D images.

The cytokine‐linked hematopoietic signaling in cancer pathways profile showed a trend toward lower scores in TgAD rats relative to WT (F (1,24) = 4.136, p = 0.053, η p 2=0.147), with no sex effect or interaction (Fs (1,24) ≤ 0.129, ps ≥ 0.723; Fig. 1 D).

BMI was correlated with MEP, whereas MIP showed a trend (p=0.053, r=0.29).

Households with four or more residents showed a trend toward increased risk (ORa = 1.6; CI 95% 0.9–2.6; p = 0.053), although this did not reach significance.

SCF+G-CSF- treated APP/PS1 mice showed a trend toward increasing TMEM119 positive microglia in the cortex when compared to the vehicle control APP/PS1 mice (p=0.053) ( Supplementary Fig. 5B ).

In the univariate analysis of the first-line setting, luminal A subtype showed a trend towards a correlation with a longer PFS ( p = 0.053).

Indeed, the Kaplan-Meier analysis showed a trend toward improved survival in the MP-NGS group (median OS: 672 vs. 138 days; log-rank p=0.053).

The rate of TIMI grade 3 flow after PCI in the high-MAGE group showed a trend toward lower than that in the low-MAGE group (92.8% vs. 96.2%, p=0.053).

The Fixed-Bearing group also showed a trend toward better WOMAC Total scores from 12 to 24 months ( p = 0.053). 3.5.

Assessment of the regulatory CD25+FoxP3+ population also showed a trend for an increased frequency in the CD4+ subset ( p = 0.053) ( Figure 3C ) and an increased frequency for the CD4-CD8- subset ( p = 0.036) ( Figure 3D ) for patients ( n = 16, P5-20) compared to controls ( n = 20).

Intravenous agents (Cangrelor/GPi) showed a trend towards lower risk of intraprocedural stent occlusion compared to oral dAPT (adjusted odds ratio [aOR] 0.30, [95% CI, 0.09–1.01], P = .053), though this did not reach statistical significance.

Among the male patients with AMI, peak CRP count showed a trend toward marking the lowest T levels in multivariable analysis (CRP 0.940, OR 0.880–1.000, p = 0.053; WBC 1.210, OR 0.700–2.080, p = 0.501).

Heart rate changes showed a trend ( p = 0.053) but did not reach statistical significance between groups ( Table 5 ). 3.4.

Birds from high-density pens showed a trend to approach cue types faster than birds from low-density pens (F 1,6 = 5.767, p = 0.053; Table 1 ).

High expression of DHRS7 was associated with higher overall survival probability ( p -value < 0.01) and showed a trend of being associated with disease-free survival probability ( p -value = 0.053); in contrast, high expression of EGFR was associated with worse survival probabilities; both overall ( p -value < 0.05) and disease-free survival ( p -value < 0.01) ( Figure 9 ).

The performance on the discrimination index of the novel object and the displaced object showed a trend between groups [NOR: F (3, 36) = 2.818, p = 0.053], SOR: [ F (3, 34) = 2.775, p = 0.056].